| Role of small-bowel endoscopy in the management of patients with inflammatory bowel disease: an international OMED–ECCO consensus A Bourreille, A Ignjatovic, L Aabakken, EV Loftus Jr, R Eliakim, ... Endoscopy 41 (07), 618-637, 2009 | 376 | 2009 |
| Association of vitamin D level with clinical status in inflammatory bowel disease: a 5-year longitudinal study TA Kabbani, IE Koutroubakis, RE Schoen, C Ramos-Rivers, N Shah, ... The American journal of gastroenterology, 2016 | 217 | 2016 |
| Surgical fundoplication in laryngopharyngeal reflux unresponsive to aggressive acid suppression: a controlled study J Swoger, J Ponsky, DM Hicks, JE Richter, TI Abelson, C Milstein, ... Clinical Gastroenterology and Hepatology 4 (4), 433. e1, 2006 | 193 | 2006 |
| Impact of obesity on the management and clinical course of patients with inflammatory bowel disease JL Seminerio, IE Koutroubakis, C Ramos-Rivers, JG Hashash, ... Inflammatory bowel diseases 21 (12), 2857-2863, 2015 | 173 | 2015 |
| Correlation between symptoms and laryngeal signs in laryngopharyngeal reflux MA Qadeer, J Swoger, C Milstein, DM Hicks, J Ponsky, JE Richter, ... The Laryngoscope 115 (11), 1947-1952, 2005 | 155 | 2005 |
| Postoperative therapy with infliximab prevents long-term Crohn’s disease recurrence M Regueiro, KE Kip, L Baidoo, JM Swoger, W Schraut Clinical Gastroenterology and Hepatology 12 (9), 1494-1502. e1, 2014 | 145 | 2014 |
| Demographic and Clinical Predictors of High Healthcare Use in Patients with Inflammatory Bowel Disease B Click, CR Rivers, IE Koutroubakis, D Babichenko, AM Anderson, ... Inflammatory bowel diseases 22 (6), 1442-1449, 2016 | 88 | 2016 |
| Persistent or recurrent anemia is associated with severe and disabling inflammatory bowel disease IE Koutroubakis, C Ramos–Rivers, M Regueiro, E Koutroumpakis, B Click, ... Clinical Gastroenterology and Hepatology 13 (10), 1760-1766, 2015 | 84 | 2015 |
| Cutaneous manifestations of Crohn disease JW Hagen, JM Swoger, LM Grandinetti Dermatologic clinics 33 (3), 417-431, 2015 | 80 | 2015 |
| Association between telephone activity and features of patients with inflammatory bowel disease C Ramos–Rivers, M Regueiro, EJ Vargas, E Szigethy, RE Schoen, ... Clinical Gastroenterology and Hepatology 12 (6), 986-994. e1, 2014 | 68 | 2014 |
| Silent Crohn's disease: asymptomatic patients with elevated C-reactive protein are at risk for subsequent hospitalization B Click, EJ Vargas, AM Anderson, S Proksell, IE Koutroubakis, CR Rivers, ... Inflammatory bowel diseases 21 (10), 2254-2261, 2015 | 62 | 2015 |
| Adalimumab for Crohn's disease in clinical practice at Mayo clinic: the first 118 patients JM Swoger, EV Loftus, WJ Tremaine, WA Faubion, DS Pardi, SV Kane, ... Inflammatory bowel diseases 16 (11), 1912-1921, 2010 | 60 | 2010 |
| Postoperative infliximab is not associated with an increase in adverse events in Crohn’s disease M Regueiro, S El-Hachem, KE Kip, W Schraut, L Baidoo, A Watson, ... Digestive diseases and sciences 56 (12), 3610-3615, 2011 | 52 | 2011 |
| Association Between Long-Term Lipid Profiles and Disease Severity in a Large Cohort of Patients with Inflammatory Bowel Disease E Koutroumpakis, C Ramos-Rivers, M Regueiro, JG Hashash, A Barrie, ... Digestive diseases and sciences 61 (3), 865-871, 2016 | 50 | 2016 |
| Physician assessment of ulcerative colitis activity correlates poorly with endoscopic disease activity M Regueiro, J Rodemann, KE Kip, M Saul, J Swoger, L Baidoo, ... Inflammatory bowel diseases 17 (4), 1008-1014, 2011 | 48 | 2011 |
| The Influence of Anti–tumor Necrosis Factor Agents on Hemoglobin Levels of Patients with Inflammatory Bowel Disease IE Koutroubakis, C Ramos-Rivers, M Regueiro, E Koutroumpakis, B Click, ... Inflammatory bowel diseases 21 (7), 1587-1593, 2015 | 44 | 2015 |
| Preventive therapy in postoperative Crohn's disease JM Swoger, M Regueiro Current opinion in gastroenterology 26 (4), 337-343, 2010 | 44 | 2010 |
| Five-Year Period Prevalence and Characteristics of Anemia in a Large US Inflammatory Bowel Disease Cohort. IE Koutroubakis, C Ramos-Rivers, M Regueiro, E Koutroumpakis, B Click, ... Journal of clinical gastroenterology, 2015 | 43 | 2015 |
| Tumor Necrosis Factor α Antagonist–associated Psoriasis in Inflammatory Diseases: An Analysis of the FDA Adverse Event Reporting System KE Kip, JM Swoger, LM Grandinetti, AM Barrie III, JB Greer, MD Regueiro Inflammatory bowel diseases 19 (6), 1164-1172, 2013 | 39 | 2013 |
| Evaluation for postoperative recurrence of Crohn disease JM Swoger, M Regueiro Gastroenterology clinics of North America 41 (2), 303-314, 2012 | 36 | 2012 |
